The findings reported herein identify EphB4 as a specific IGF-II target via an insulin receptor isoform A- triggered signal and are in line with a strict functional dependence of EphB4 from the autocrine IGF-II-IRA-stimuli in order to modulate its reverse signaling and the cellular effects resulting by their co-expression in cancer. Here, EPHB4 is linked to cancer.